News
MARCH 25, 2026
Paul Hastings Advises TD Cowen and LifeSci Capital on Sol-Gel Technologies’ Underwritten Offering
Read Time: 1 min
Paul Hastings LLP advised TD Cowen and LifeSci Capital as joint bookrunning managers in Sol-Gel Technologies’ (Nasdaq: SLGL) $33.1 million underwritten offering of 459,112 ordinary shares at a price of $72.00 per share. The offering closed on March 25, 2026.
Equity Capital Markets and Corporate Life Sciences chair Seo Salimi and partner Will Magioncalda led the Paul Hastings team, which included associates Greg Drozdzal and Will Yu.
More details can be found here.
With widely recognized elite teams across 18 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world's leading investment banks, asset managers and corporations.